Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Return on Equity: 2020-2025

Historic Return on Equity for Benitec Biopharma (BNTC) over the last 5 years, with Mar 2025 value amounting to -0.11%.

  • Benitec Biopharma's Return on Equity rose 148.00% to -0.11% in Q1 2025 from the same period last year, while for Mar 2025 it was -0.11%, marking a year-over-year increase of 148.00%. This contributed to the annual value of -0.91% for FY2024, which is 1149.00% up from last year.
  • As of Q1 2025, Benitec Biopharma's Return on Equity stood at -0.11%, which was up 17.32% from -0.14% recorded in Q4 2024.
  • In the past 5 years, Benitec Biopharma's Return on Equity ranged from a high of -0.11% in Q1 2025 and a low of -7.78% during Q2 2023.
  • Moreover, its 3-year median value for Return on Equity was -1.15% (2023), whereas its average is -1.84%.
  • In the last 5 years, Benitec Biopharma's Return on Equity slumped by 434bps in 2023 and then surged by 704bps in 2024.
  • Benitec Biopharma's Return on Equity (Quarterly) stood at -1.32% in 2021, then decreased by 24bps to -1.56% in 2022, then surged by 41bps to -1.15% in 2023, then surged by 101bps to -0.14% in 2024, then soared by 148bps to -0.11% in 2025.
  • Its Return on Equity stands at -0.11% for Q1 2025, versus -0.14% for Q4 2024 and -0.38% for Q3 2024.